IL147581A0 - New interferon beta-like molecules - Google Patents

New interferon beta-like molecules

Info

Publication number
IL147581A0
IL147581A0 IL14758100A IL14758100A IL147581A0 IL 147581 A0 IL147581 A0 IL 147581A0 IL 14758100 A IL14758100 A IL 14758100A IL 14758100 A IL14758100 A IL 14758100A IL 147581 A0 IL147581 A0 IL 147581A0
Authority
IL
Israel
Prior art keywords
molecules
interferon beta
new interferon
new
beta
Prior art date
Application number
IL14758100A
Original Assignee
Maxygen Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maxygen Aps filed Critical Maxygen Aps
Publication of IL147581A0 publication Critical patent/IL147581A0/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
IL14758100A 1999-08-27 2000-08-25 New interferon beta-like molecules IL147581A0 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DKPA199901197 1999-08-27
US16078299P 1999-10-21 1999-10-21
DKPA199901691 1999-11-26
DKPA200000194 2000-02-07
DKPA200000363 2000-03-07
DKPA200000642 2000-04-14
PCT/DK2000/000471 WO2001015736A2 (en) 1999-08-27 2000-08-25 Interferon-beta conjugates

Publications (1)

Publication Number Publication Date
IL147581A0 true IL147581A0 (en) 2002-08-14

Family

ID=27545189

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14758100A IL147581A0 (en) 1999-08-27 2000-08-25 New interferon beta-like molecules

Country Status (14)

Country Link
EP (1) EP1328295A2 (en)
JP (1) JP2003527090A (en)
KR (1) KR20020034181A (en)
CN (1) CN1501815A (en)
AU (1) AU6687000A (en)
BR (1) BR0013638A (en)
CA (1) CA2380760A1 (en)
CZ (1) CZ2002521A3 (en)
HU (1) HUP0302674A2 (en)
IL (1) IL147581A0 (en)
MX (1) MXPA02001969A (en)
NO (1) NO20020929L (en)
SK (1) SK2942002A3 (en)
WO (1) WO2001015736A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2630278T3 (en) * 1998-10-16 2017-08-21 Biogen Ma Inc. Interferon beta-1a polymer conjugates and uses thereof
ES2265693T3 (en) 1998-10-16 2007-02-16 Biogen Idec Ma Inc. FUSION PROTEINS WITH INTERFERON-BETA AND USES.
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
WO2002036628A2 (en) * 2000-11-02 2002-05-10 Maxygen Aps New multimeric interferon beta polypeptides
YU48703A (en) 2001-02-27 2006-05-25 Maxygen Aps New interferon beta-like molecules
AU2002254174A1 (en) * 2001-03-13 2002-09-24 Vical Incorporated Interferon-beta polynucleotide therapy for autoimmune and inflammatory diseases
KR100511749B1 (en) * 2001-11-06 2005-09-02 선바이오(주) Modified interferon-beta, and chemically modified conjugates thereof
EA009783B1 (en) 2002-01-18 2008-04-28 Байоджен Айдек Ма Инк. Polyalkylene glycolhaving a moiety for conjugation of a biologically active compound
AU2003254641A1 (en) * 2002-08-28 2004-03-19 Maxygen Aps Interferon beta-like molecules for treatment of cancer
PL219741B1 (en) * 2002-12-26 2015-07-31 Mountain View Pharmaceuticals Polymer conjugates of interferon-beta with enhanced biological potency
CN101880326B (en) * 2003-08-25 2018-02-16 东丽株式会社 Interferon beta compound
EP1674113A1 (en) * 2004-12-22 2006-06-28 F. Hoffmann-La Roche Ag Conjugates of insulin-like growth factor-1 (IGF-1) and poly(ethylene glycol)
CN101506232A (en) * 2006-08-08 2009-08-12 诺瓦提斯公司 Recombinant interferon-beta with enhanced biological activity
US7625555B2 (en) 2007-06-18 2009-12-01 Novagen Holding Corporation Recombinant human interferon-like proteins
CL2008002399A1 (en) * 2007-08-16 2009-01-02 Pharmaessentia Corp Substantially pure conjugate having a polymeric portion, a protein portion (interferon alpha 2b) and an aliphatic binder of 1 to 10 carbon atoms, useful in the treatment of hepatitis b or c.
CN104043112B (en) * 2014-07-01 2016-03-30 哈药集团生物工程有限公司 A kind of ointment pharmaceutical composition containing recombinanthumaninterferonα-2b (pseudomonas)
KR20230079520A (en) 2014-11-06 2023-06-07 파마에센시아 코퍼레이션 Dosage Regimen for PEGylated Interferon
US11236141B2 (en) * 2016-05-13 2022-02-01 Orionis Biosciences BV Targeted mutant interferon-beta and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4917888A (en) * 1985-06-26 1990-04-17 Cetus Corporation Solubilization of immunotoxins for pharmaceutical compositions using polymer conjugation
US5206344A (en) * 1985-06-26 1993-04-27 Cetus Oncology Corporation Interleukin-2 muteins and polymer conjugation thereof
JP2524586B2 (en) * 1985-06-26 1996-08-14 シタス コーポレイション Solubilization of proteins for pharmaceutical compositions utilizing polymer conjugation
US4904584A (en) * 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
US5218092A (en) * 1988-09-29 1993-06-08 Kyowa Hakko Kogyo Co., Ltd. Modified granulocyte-colony stimulating factor polypeptide with added carbohydrate chains
IL113280A (en) * 1994-04-12 2004-12-15 Res Dev Foundation Composition for treating auto-immune diseases using type one interferons
US5738846A (en) * 1994-11-10 1998-04-14 Enzon, Inc. Interferon polymer conjugates and process for preparing the same
EP1017794A1 (en) * 1997-02-06 2000-07-12 Novo Nordisk A/S Polypeptide-polymer conjugates having added and/or removed attachment groups
NZ502375A (en) * 1997-07-14 2001-11-30 Bolder Biotechnology Inc The addition of non-natural cysteine derivatives to cause the protein to act as antagonists of the GH family
ES2630278T3 (en) * 1998-10-16 2017-08-21 Biogen Ma Inc. Interferon beta-1a polymer conjugates and uses thereof

Also Published As

Publication number Publication date
HUP0302674A2 (en) 2003-11-28
JP2003527090A (en) 2003-09-16
BR0013638A (en) 2002-05-14
EP1328295A2 (en) 2003-07-23
MXPA02001969A (en) 2003-07-21
NO20020929D0 (en) 2002-02-26
CA2380760A1 (en) 2001-03-08
NO20020929L (en) 2002-04-25
WO2001015736A2 (en) 2001-03-08
SK2942002A3 (en) 2002-08-06
KR20020034181A (en) 2002-05-08
AU6687000A (en) 2001-03-26
WO2001015736A3 (en) 2003-05-22
CZ2002521A3 (en) 2002-05-15
CN1501815A (en) 2004-06-02

Similar Documents

Publication Publication Date Title
IL147581A0 (en) New interferon beta-like molecules
AU3662101A (en) Cd40-binding apc-activating molecules
IL148218A0 (en) New phenylpiperazines
GB9921125D0 (en) Proteins
AU144192S (en) Pump
GB9817739D0 (en) Pumps
GB9903430D0 (en) Novel proteins
AU141528S (en) Counter
GB0022670D0 (en) Molecules
GB9920000D0 (en) Polypeptides
GB0002625D0 (en) Dendroaspin molecules
GB9813704D0 (en) Pumps
GB9811172D0 (en) Virus production
DE60034798D1 (en) Mischer
GB0019705D0 (en) Factor
GB9912635D0 (en) Molecules
GB9904877D0 (en) Kounta -attak!!!
GB9818690D0 (en) Pumps
GB9908645D0 (en) Proteins
GB9907805D0 (en) Proteins
GB9907114D0 (en) Proteins
GB9912783D0 (en) Viras
GB9912229D0 (en) Millenium boardmaster hop-up
GB2346579B (en) Plane
GB9927157D0 (en) Releasable Ligand